Saudi Arabia Biopharmaceutical Market Size & Outlook
The biopharmaceutical market in Saudi Arabia is expected to reach a projected revenue of US$ 2,509.2 million by 2033. A compound annual growth rate of 5% is expected of Saudi Arabia biopharmaceutical market from 2026 to 2033.
Revenue, 2025 (US$M)
$1,668.0
Estimate, 2026 (US$M)
$1,778.1
Forecast, 2033 (US$M)
$2,509.2
CAGR, 2026 - 2033
5.0%
Global Market
Related Markets
Saudi Arabia biopharmaceutical market highlights
- The Saudi Arabia biopharmaceutical market generated a revenue of USD 1,668.0 million in 2025 and is expected to reach USD 2,509.2 million by 2033.
- The Saudi Arabia market is expected to grow at a CAGR of 5% from 2026 to 2033.
- In terms of segment, monoclonal antibody was the largest revenue generating molecule type in 2025.
- Hormone is the most lucrative molecule type segment registering the fastest growth during the forecast period.
Biopharmaceutical market data book summary
| Market revenue in 2025 | USD 1,668.0 million |
| Market revenue in 2033 | USD 2,509.2 million |
| Growth rate | 5% (CAGR from 2026 to 2033) |
| Largest segment | Monoclonal antibody |
| Fastest growing segment | Hormone |
| Historical data | 2021 - 2024 |
| Base year | 2025 |
| Forecast period | 2026 - 2033 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Monoclonal Antibody, Interferon, Insulin, Growth and Coagulation Factor, Erythropoietin, Vaccine, Hormone |
| Key market players worldwide | F. Hoffmann-La Roche Ltd., Novartis AG ADR, AbbVie Inc., Johnson & Johnson Services, Inc., Merck & Co., Inc., Pfizer Inc., Bristol-Myers Squibb Company, Sanofi SA, GSK PLC ADR, AstraZeneca PLC, Takeda Pharmaceutical Company Limited, Biogen Inc, Eli Lilly and Company, Novo Nordisk A/S ADR, Amgen Inc. |
Other key industry trends
- In terms of revenue, Saudi Arabia accounted for 0.3% of the global biopharmaceutical market in 2025.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2033.
- In Middle East & Africa, Saudi Arabia biopharmaceutical market is projected to lead the regional market in terms of revenue in 2033.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 1,126.0 million by 2033.
No credit card required*
Publish Date: Mar 10, 2025
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Three ways to get this data
Subscribe to the databook, customize it, or ask a question.Horizon Databook
Unlock every chart on this page and get dashboard access
- Statistics1.2M+ across all markets
- Databooks30K+ global, 120K+ country
- Companies200K+ profiles
- ExportPDF, Dashboard, XLS & PNG, licensed to cite
Customize it
Customize data as per your requirement
- AddCountries, segments, years
- RecutTo your product definition
- ExtendCompany-level detail
- OrA bespoke databook
- Turnaround5–10 working days
Ask Prism AI
A cited answer in seconds
- Corpus30,000 studies, 1.2M points
- ScopeAll markets, not just this
- CitationTraced to report & table
- HonestySays "not covered" if so
- SpeedSeconds, not days
Biopharmaceutical Market Scope
Biopharmaceutical Market segmentation & scope
Others
Biopharmaceutical Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|---|---|---|---|
| Novartis AG ADR | View profile | 76,057 | Lichtstrasse 35, Basel, Switzerland, 4056 | www.novartis.com |
| Sanofi SA | View profile | 87,994 | 46, avenue de la Grande Armée, Paris, France, 75017 | www.sanofi.com |
| GSK PLC ADR | View profile | 70,200 | 980 Great West Road, Brentford, Middlesex, United Kingdom, TW8 9GS | www.gsk.com |
| Novo Nordisk A/S ADR | View profile | 66,015 | Novo Alle 1, Bagsvaerd, Denmark, 2880 | www.novonordisk.com |
| AstraZeneca PLC | View profile | 89,900 | 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, United Kingdom, CB2 0AA | www.astrazeneca.com |
| Biogen Inc | View profile | 7,570 | 225 Binney Street, Cambridge, MA, United States, 02142 | www.biogen.com |
| AbbVie Inc. | View profile | - | - | - |
| F. Hoffmann-La Roche Ltd. | View profile | - | - | - |
| Pfizer Inc. | View profile | - | - | - |
| Bristol-Myers Squibb Company | View profile | - | - | - |
Saudi Arabia Biopharmaceutical Market Outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to Biopharmaceutical Market Outlook will help companies and investors design strategic landscapes.
Monoclonal Antibody was the largest segment with a revenue share of 68.02% in 2025.
Horizon Databook has segmented the Saudi Arabia biopharmaceutical market based on monoclonal antibody, interferon, insulin, growth and coagulation factor, erythropoietin, vaccine, hormone covering the revenue growth of each sub-segment from 2021 to 2033.
- Saudi Arabia Biopharmaceutical Market Molecule Type Outlook (Revenue, USD Million , 2021-2033)
- Monoclonal Antibody
- Interferon
- Insulin
- Growth and Coagulation Factor
- Erythropoietin
- Vaccine
- Hormone
- Others
- Saudi Arabia Biopharmaceutical Market Disease Outlook (Revenue, USD Million , 2021-2033)
- Oncology
- Blood Disorder
- Metabolic Disease
- Infectious Disease
- Cardiovascular Disease
- Neurological Disease
- Immunology
- Other Applications
- Saudi Arabia Biopharmaceutical Market Drug Type Outlook (Revenue, USD Million , 2021-2033)
- Proprietary (Branded)
- Biosimilars
- Saudi Arabia Biopharmaceutical Market Drug Development Outlook (Revenue, USD Million , 2021-2033)
- Outsource
- In-house
- Saudi Arabia Biopharmaceutical Market Formulation Outlook (Revenue, USD Million , 2021-2033)
- Injectables (IV, IM, SC)
- Inhalation/Nasal Sprays
- Other Formulations
- Saudi Arabia Biopharmaceutical Market Route of Administration Outlook (Revenue, USD Million , 2021-2033)
- Parenteral (IV, IM, SC)
- Inhalation/Nasal
- Other Routes
- Saudi Arabia Biopharmaceutical Market Prescription Type Outlook (Revenue, USD Million , 2021-2033)
- Prescription Medicines
- Over-the-counter (OTC) Medicines
- Saudi Arabia Biopharmaceutical Market Sales Channel Outlook (Revenue, USD Million , 2021-2033)
- Retail Pharmacies
- Non-retail
Reasons to subscribe to Biopharmaceutical Market Outlook databook
- Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
- Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
- Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
- Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
- Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Biopharmaceutical Market Outlook databook
- Our clientele includes a mix of Biopharmaceutical Market Outlook companies, investment firms, advisory firms & academic institutions.
- 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
- Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
- The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia Biopharmaceutical Market Outlook, including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia Biopharmaceutical Market Outlook from 2021 to 2033, including revenue numbers, major trends, and company profiles.
Saudi Arabia Biopharmaceutical Market, 2021-2033 (US$M)
Saudi Arabia biopharmaceutical market statistics, by molecule type, 2021-2033 (US$M)
